Skip to main content
. 2022 Mar 2;16:855470. doi: 10.3389/fnins.2022.855470

TABLE 1.

Clinical characteristics of participants at baseline in each group.

Characteristic CD patients (n = 20) Healthy controls (n = 22) P-value
Gender (male/female) 8/12 10/12 0.721a
Age (years)  33.00 ± 13.35 37.82 ± 7.40 0.151b
CDAI 196.03 ± 33.43 N/A
SAS 35.45 ± 7.32 N/A
SDS 41.60 ± 7.38 N/A
Disease duration (months)  61.00 ± 70.58 N/A

aχ2 test; bIndependent t-test for continuous data (mean ± SD). CD, Crohn’s disease; CDAI, CD activity index; SAS, Self-rating Anxiety Scale; SDS, Self-rating Depression Scale; and N/A, not applicable.

HHS Vulnerability Disclosure